[Contribution of the DST (dexamethasone suppression test) to the diagnosis, prognosis and treatment of depression].
Reviewing biological research in depressive illness, this work focuses on the DST as most practical and useful investigation in today's psychiatry. This study is empirically based on more than 10,000 test results from in- and outpatients recruited over six years. This work might be the missing link between highly selective and sometimes difficult to integrate university research and the daily practice. This experience with the DST on various areas is illustrated with numerous cases. Considerable attention goes to DST as diagnostic marker, prognostic indicator, DST and postpartum psychosis, DST and schizo-affective disorder, DST and masked depression. Possibilities and limits of this important aid in psychiatry are discussed in connection with measuring psychiatric illness and integrate approach.
Tanghe
A
A
Service de neuropsychiatrie de la Clinique Sint-Franciscus-Xaverius, Brugge.
van Renynghe de Voxvrie
G
G
D000928:Antidepressive Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000737:chemistry; D001714:Bipolar Disorder / Q000378:metabolism; D001923:Brain Chemistry; D003866:Depressive Disorder / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D003907:Dexamethasone; D003937:Diagnosis, Differential; D006801:Humans; D011379:Prognosis
D000928:Antidepressive Agents; D015415:Biomarkers; D003907:Dexamethasone
Contribution du DST au diagnostic, au pronostic et au traitement de la dépression.